New heart ablation technique targets hidden drivers of AFib

NCT ID NCT07390175

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to treat persistent atrial fibrillation (AFib) by targeting specific high-frequency areas in the heart that may be driving the condition. Researchers will compare this new ablation method to standard treatment in 78 adults with long-lasting AFib or recurrent ventricular fibrillation. The goal is to see if this approach can stop AFib more effectively and safely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
catheter ablation procedure
What this could lead to
If successful, this could lead to a more effective and safer ablation technique for persistent atrial fibrillation, reducing recurrence and improving quality of life.
What could go wrong
This is an early-stage study with a small number of participants. The new ablation approach may not be more effective than standard treatment and carries typical risks of cardiac ablation, such as bleeding or heart rhythm disturbances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABLATION TREATMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Clínico San Carlos

    RECRUITING

    Madrid, Madrid, 28040, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.